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Abstract
Background—Although direct medical costs for constipation related medical visits are thought
to be high, to date there have been no studies examining longitudinal resource utilization in adults
with constipation.
Aim—To estimate the incremental direct medical costs associated with constipation in women.
Methods—This is a nested case-control study. The study population consisted of all mothers of
5,718 children in the population-based birth cohort born during 1976-1982 in a community. The
cases presented to the medical facilities with constipation. The controls were randomly selected
and matched to cases in a 2:1 ratio. Direct medical costs for constipated women and controls were
collected for the years 1987-2002.
Results—We identified 168 women with a diagnosis of constipation. The total direct medical
costs over a 15-year period for constipated subjects were more than double those of controls
($63,591 [95%CI: 49,786- 81,396]) vs. $24,529 [95%CI: 20,667-29,260]). The overall outpatient
costs for constipated women were $38,897 (95% CI: 31,381-48,253) compared to $15,110 (95%
CI: 12,904-17,781) for controls. The median annual outpatient visits for constipated women was
0.16 compared to 0.11 for controls.
Conclusion—Women with constipation have significantly higher medical care utilization and
expenditures compared to women without constipation.
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Constipation is a chronic and common disorder, which presents as difficult, infrequent stool
passage or a feeling of incomplete evacuation.1-3 The prevalence of constipation from
population-based studies in North America has been estimated to be as high as 27% in
adults, depending on definition, demographic factors, and sampling.1-7 In a systemic review
of the burden of digestive diseases in the United States (U.S.) using a national database in
2004,8 Everhart et al. showed that constipation was the second most common ambulatory
care diagnosis (6.3 million visits) among digestive diseases, after gastroesophageal reflux
disease.
The evidence suggests that many patients have constipation-associated symptoms on a long-
term basis.9, 10 Johanson and Kralstein9 reported that about 70% patients had constipation
for more than two years using the web-based survey of the Knowledge Networks Panel.
Talley et al.10 determined that in the general population, 89% of adults surveyed reported no
change in their gastrointestinal symptoms during an intervening 12-20 month period. Thus,
constipated subjects may present repeatedly for constipation over a prolonged period of
time, which would likely contribute to an increased number of outpatient visits, diagnostic
evaluations, and inpatient admissions. Although direct medical costs for constipation-related
medical visits are thought to be high, to date there is no study examining longitudinal
resource utilization in adults with constipation. The majority of studies, in fact, have relied
on cross sectional medical costs for constipation.8, 11, 12 Sonnenberg et al.12 estimated that
visits for constipation resulted in costs of $29 million (1985 value) for ambulatory visits. In
a recent review,8 Everhart et al. estimated that in the U.S., the direct cost for constipation
was $1.6 billion in 2004 (using the Verispan database).
In order to accurately estimate the longitudinal medical costs of a particular disease or
disorder, a large well-defined cohort with a long duration of follow up as well as direct data
on the medical costs is required. However, many longitudinal cohorts including the
Framingham Heart Study13 and Nurses' Health Study14 do not have information on medical
resource utilization or economic costs. The Rochester Epidemiology Project (REP) has
captured all diagnoses and procedures of residents in a local community since 1966.15, 16
Using the REP, we created a birth cohort17-19 which consisted of all children born from
1976 and 1982 to mothers who were residents of the community; we have previously
reported that the incidence of constipation in children in this birth cohort was 3.9 per 1000
person-years, and children with constipation at an early age repeatedly presented for medical
visits due to constipation.19 The aim of the present study was to estimate incremental direct
medical costs and type of health care associated with constipation in women over a
prolonged period of time in a community.
Methods
Setting
Olmsted County, Minnesota, is a metropolitan and rural area 90 miles southeast of
Minneapolis, Minnesota. Census data from the 1990 population, representing the years the
children from this birth cohort were in school, indicated the population was 70,745 (75%
were age <45 years), and estimated to be 96% Caucasian; sociodemographically, the
community is similar to the U.S. Caucasian population.15, 16 Over 95% of county residents
receive their medical care from one of the two group practices in the community (Mayo
Clinic and Olmsted Medical Center). Mayo Clinic has maintained a common medical record
system with its two affiliated hospitals (Saint Marys and Rochester Methodist) for over 90
years.15, 16 Recorded diagnoses and surgical procedures are indexed, including the
diagnoses made for outpatients seen in office or clinic consultations, emergency room visits
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or nursing home care, as well as the diagnoses recorded for hospital inpatients, at autopsy
examination or on death certificates. This system was further developed by the REP, which
created similar indices for the records of other providers of medical care to local residents,
most notably the Olmsted Medical Group and its affiliated Olmsted Community Hospital.
Thus, details of the medical care provided to the residents of Olmsted County are available
for study. Annually, over 80% of the entire population is attended by one or both of these
two practices, and nearly everyone is seen at least once during any given three-year
period.15 Therefore, the REP medical records linkage system also provides what is
essentially an enumeration of the population from which samples can be drawn.
Study subjects from the 1976-1982 Rochester Birth Cohort
A cohort of all women who were residents of Rochester, Minnesota and who had children
born between January 1, 1976 and December 31, 1982, was utilized. As approved by the
Institutional Review Boards of the Mayo Clinic and Olmsted Medical Center, we used this
system previously to draw the birth cohort which consisted of all children born between
1976 and 1982, to mothers residing in Olmsted County, Minnesota, comprising the
Minnesota Independent School District 535 (n= 8548) in the city of Rochester.17-19 Subjects
were identified through computerized birth certificate information from the Minnesota
Department of Health, Division of Vital Statistics. The target population for this study
consisted of 4075 women, not actively denying research authorization, whose children at or
after the age of 5 years all still lived in Rochester. The women's length of follow-up was
confirmed utilizing the REP.
Identification of cases with constipation
Through the REP, all diagnoses and surgical procedures recorded at Rochester medical
facilities are indexed continuously for automated retrieval. This diagnostic index expedites
retrieval of the unit (or dossier) medical record, which includes the history of all encounters
in the hospital, community and ambulatory medical and social services, emergency
department, outpatient clinics, and home visits, as well as laboratory and psychologic test
results from birth until patients no longer reside within the community.
Case and control ascertainment
Constipation Cases: The cases included mothers who presented to Olmsted County medical
facilities with constipation from the birth cohort. All mothers diagnosed with constipation
were identified by using the diagnostic index developed by the REP. The constipation cases
were identified as having one or more of the following diagnostic or surgical codes:
constipation, H-ICDA-8 (Hospital Adaptation of the International Classification of
Diseases) 05640112 or ICD-9 564; obstipation, H-ICDA-8 05640111; constipation
(functional), ICD-0 564.9. The diagnostic index was designed to be sensitive and thus this
search should capture all clinically diagnosed cases.
Controls: For each identified and reviewed case, we randomly selected two age-matched
controls from the pool of mothers in the birth cohort who did not meet the constipation
definition; that is, did not have one of the relevant HICDA or ICD-9 diagnoses for
constipation. Thus, the controls were matched to cases in a 2:1 ratio, matching on age and
years of follow-up.
Cost and Utilization Data
Beginning in January 1987, resource use and associated charges data from Mayo Clinic and
Olmsted Medical Center were collected. This claims-based database contains information on
medical resource utilization, associated charges, and estimated economic costs for patients
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receiving care at either the Olmsted Medical Group or the Mayo Clinic and their associated
inpatient facilities. The Olmsted County Healthcare Expenditure and Utilization Database
(OCHEUD) provides a standardized inflation-adjusted estimate of costs for each service or
procedure provided locally in constant dollars. Specifically, using a “bottom-up” (also
referred to as micro-costing) costing approach, OCHEUD groups resource utilization into
the Medicare Part A and B classification system. Part A billed charges are adjusted by using
hospital cost-to-charge ratios and Part B physician services are valued by using Medicare
reimbursement rates.
Although the services provided represent the clinical practice patterns of Mayo Clinic and
Olmsted Medical Center providers, the value of each unit of service has been adjusted to
national norms by use of widely accepted valuation techniques.20 OCHEUD provides an
estimated economic cost for each line item in the billing record and allows the aggregation
of costs into categories deemed relevant to a particular study.20
Data collection—Techniques for data collection have been previously described.18, 19, 21
Detailed sociodemographic factors were collected at birth in the 1976-1982 birth cohort. To
determine factors that may influence medical presentation for a condition, birth certificate
information was evaluated.
For the selected comorbidities status in the cases and controls, comorbidities were defined as
an occurrence of at least one diagnosis within the time frame of the study. The diagnostic or
surgical codes (Table 1) were selected based on our a priori expectation that they could have
an impact on constipation status and medical costs, and were prevalent in the population.
Statistical Analyses
Descriptive statistics on baseline factors (e.g. age, gender, proportion of cesarean births,
etc.) as well as sociodemographic factors are presented as means with standard deviations or
frequencies with percentages. All categorical descriptive variables were compared using the
Chi-square test statistic or Fisher's exact when appropriate. Continuous variables were
compared using the Wilcoxon rank sum test. The unadjusted mean cost per year is presented
for descriptive purposes only, as is the interquartile range and the range per patient per year
for the entire time frame.
The effect of constipation on total costs during a given year on all women was assessed
using two-part models to account for the zero values during a given year.22 For the two-part
model specifications, logistic regression was used in part 1 to estimate the probability of
costs conditional on patient characteristics; part 2 was employed with an inverse Gaussian
distribution function with log link in cost models. Confidence intervals of estimated costs
were generated by bootstrapping method.23 Three time frames were chosen and adjusted by
comorbid conditions. The only comorbid conditions that were counted were those that had
been found within the given year or previous to the year being analyzed.
The Tian and Huang24 method was used to assess the overall mean estimated costs. It is a
two-part model for censored medical costs. The first part assumes a parametric model, in
this case logistic regression for the probability of having a positive cost over 15 years with
covariates. The second part uses a linear regression model for the positive costs. The
censoring caused by incomplete follow up is addressed by applying the inverse probability
weighting method to the two part model. This method allows for testing to see if a covariate
has any effect on the total medical costs as well an estimation of the mean medical costs for
individuals.
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Similarly, this two-part model was employed to evaluate the predictors of costs within a
multivariate model for those patients with constipation. Each comorbid condition that
contained measurable counts was entered into the model predicting outpatient and total
costs. For each variable entered into the model, an estimate of the percentage change in costs
associated with each clinical characteristic is generated, contingent upon whether patients
have positive costs. However, 4 (2.4%) patients did not have a positive value for total costs
in the cohort, and 4 (2.4%) had no outpatient costs.
All calculated p-values were two-sided and p-values less than 0.05 were considered
statistically significant. Statistical analyses was performed using SAS (SAS Institute, Cary,
NC) and R - General (R Development core Team [2008)] software packages.25
Results
A total of 4075 women were eligible for this study. Among the women who did not deny
research authorization, a total of 168 subjects with a medical diagnosis of constipation were
identified. The mean age of cases when medical costs were first available was 33.2 years (±
5.7), and the mean age of controls was 33.2 years (± 5.7) (table 2).
Table 2 summarizes the sociodemographic characteristics and comorbid conditions in
constipated women and controls. There were no significant differences between
sociodemographic comparisons such as education level, proportion with cesarean delivery,
complications of delivery, legitimate births, or prenatal visits.
Medical visits and comorbid conditions
Annual medical visits and comorbid conditions of constipated women between 1987 and
2002 versus controls are summarized in Table 3. Cases used more of all types of medical
services than their matched controls. Emergency department visits were the most frequently
used type of services by constipated subjects, followed by outpatient care and inpatient care.
In addition, more constipated women used hospital outpatient and inpatient care and the
emergency department compared with controls. Notably, the mean annual number of
emergency department visits for constipated women were 0.24 compared to 0.15 for
controls (p<0.0001) (Table 3). Interestingly, 15.5 % of constipated subjects received no
medical diagnosis for one of the selected comorbid conditions compared with 33.6% of the
matched controls (p < .0001) (Table 3). Moreover, constipated women were more likely to
present for co-morbid abdominal pain, as well as somatic and psychological conditions
during the 15-year period.
Estimated direct medical costs and comorbid conditions
The medical costs over the entire time period for cases ($63,591 [95%CI: 49,786- 81,396])
were more than double those of controls ($24,529 [95%CI: 20,667-29,260]) for the total
direct medical costs over 15-year period. The overall outpatient costs for constipated women
were also more than double those of controls ($38,897 [95% CI: 31,381-48,253] vs. $15,110
[95% CI: 12,904-17,781]) (Table 4). Moreover, based on the mean total costs, the average
costs per patient per year were higher than those of controls ($3,131 vs. $1,858, Table 4).
Furthermore, the estimated average annual outpatient cost of cases was $1,791 compared to
$964 for controls (Table 4).
Figure 1 shows the total annual observed mean costs of constipated women and controls
according to the year. Overall, cases consistently had higher health care costs between 1987
and 2002, even after adjusting for other comorbid conditions such as abdominal pain and
back pain. Figure 2 shows the annual observed outpatient medical costs for constipated
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women and controls. Similarly, cases consistently had higher outpatient care costs after
adjusting for other comorbid conditions over a 15-year period.
Table 5 summarizes the impact of comorbid conditions on direct medical costs. After
adjusting for other comorbid conditions, depression and dyspepsia were all significantly
associated with both total and outpatient medical costs. The association of abdominal pain
and heartburn/GERD were borderline significantly associated with outpatient medical costs
(Table 5). Depression was associated with a 56% increase in total costs and 50% in
outpatient medical costs. However, dyspepsia was found to have a decrease in medical costs
(-77% in total and -84% in outpatient). Thyroid disorders, anxiety, back pain and headache
were not significantly related to direct medical costs (Table 5).
Interactions between co-morbid conditions and constipation were examined for both total
medical costs and outpatient medical costs. Only dyspepsia was found to have a significant
interaction with constipation status. Among constipated women, patients with dyspepsia
were found to have a decrease in both their total (36.7%) and outpatient (55.4%) costs
compared to those without dyspepsia. However, women without constipation (controls) had
a marginal increase in costs (1.2% and 2.9%, respectively) in patients with dyspepsia versus
those without dyspepsia.
Discussion
This is to our knowledge the first population-based longitudinal study to present U.S. data
on the costs related with constipation over a 15-year timeframe. We observed that women
with a diagnosis of constipation consistently used more of all types of medical services,
from outpatient clinics to inpatient hospitalizations and emergency department visits,
compared to matched controls. Moreover, women with constipation were more likely to
present for abdominal pain or for somatic or psychological co-morbid conditions over a 15-
year period. Overall, women with constipation consistently had higher health care costs over
time; specifically, the overall annual medical costs for women with constipation are more
than twice that of controls.
Constipation is one of the most common digestive disorders in the United States.2, 26, 27
Choung et al.27 showed that the cumulative incidence of chronic constipation over 12 years
was almost one in six. Moreover, physician office visit related to constipation have
dramatically increased.28 Shah et al.28 studied the national trends in physician office visits
associated with constipation between 1993 and 2004 using National Ambulatory Medical
Care Survey (NAMCS) and the National Hospital Ambulatory Care Survey (NHAMCS) in
USA. They showed that ambulatory visits for constipation increased from 4 million (95% CI
3.3–4.7 million) ambulatory visits for constipation annually during 1993–1996 period to
7.95 million (95% CI 6.6–9.4 million) visits during the 2001–2004 period. Not surprisingly,
in a recent database analysis by Everhart et al.8 on the burden of digestive diseases in the
U.S., constipation was the second most common ambulatory care diagnosis after
gastroesophageal reflux disease among gastrointestinal diseases. They also showed that
hospitalizations for chronic constipation were uncommon. Our study has confirmed these
observations; we found a relatively lower number of hospitalizations compared to other
medical services and a relatively higher number of outpatient clinic visits. However, all
medical services were more frequently used by constipated women. In addition, our study
showed that outpatient medical visits for comorbid somatic pain, abdominal pain, and
psychological conditions are disproportionately higher for women who present with
constipation. This is consistent with other data. Mason et al.29 studied psychological
morbidity in women with constipation; they reported that patients with constipation had
significantly increased psychological and social morbidity (anxiety, depression, and social
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dysfunction) and increased somatization. Other studies have shown that constipation is
linked to comorbid conditions, including somatic pain, psychologic conditions, abdominal
pain, and other digestive diseases.27, 29-31 Thus, it is conceivable that constipation directly
and indirectly contributes to high usage of health care resources. Our study showed that
women with dyspepsia and constipation actually had lower total (36.7%) and outpatient
(55.4%) costs compared to those without dyspepsia, but dyspepsia is unlikely to have had
any effects on incremental medical costs because only 14 patients out of 168 constipated
women had dyspepsia. Confounding variables might explain less consulting behavior in
patients with dyspepsia, such as younger age, although we tried to adjust for
confounding.32, 33
Martin et al.34 studied the economic burden of constipation based on an analysis of three
national surveys (the 2001 National Ambulatory Medical Care Survey, the 2001 National
Hospital Ambulatory Medical Care Survey, and the 2001 National Hospital Discharge
Survey). They reported that the costs associated with medical care for constipation totaled
$235 million in 2001.34 This estimate does not include the costs of over-the-counter and
prescription drugs or the cost of care when constipation was determined to be a complication
of other disease or a comorbid condition. In another study using the California Medicaid
program (Medi-Cal), Singh et al.35 showed that constipation-related total Medi-Cal
reimbursement over a 15-month period was $18,891,008, representing a substantial
economic loss for the Medicaid system. We obtained data on the incremental medical costs
for women with constipation compared to matched controls in longitudinal observations
over 15 years. In the current study, the average annual incremental total medical costs over a
15-year period in a woman with constipation was $1,272 more than controls, and the
average annual incremental medical costs of outpatient care in a woman with constipation
was $ 827 more than controls. Because our study compared constipated subjects to controls,
it is reasonable to conclude that constipation contributes to significant incremental medical
costs.
This study had some potential limitations. First, the study could not include all subjects with
constipation in a community, because subjects with symptoms not seeking medical attention
would not be identified. Thus, our study likely underestimates the actual direct cost burden
of constipation. In this study we were unable to look at indirect costs, such as workday
absences or drug use, and thus our cost estimations probably underestimate the impact of the
disorder. Moreover, the high medical costs in constipated women might be related to other
medical conditions or treatments such as opioid use, surgery, or chemotherapy, etc.
However, we still observed higher medical costs in constipated women compared to controls
over a 15-year period after adjusting for other comorbid conditions including abdominal
pain, depression, and headache. Second, these data are only generalizable to the white U.S.
population because the racial composition of this community is predominantly Caucasian.15
Moreover, the services and the utilization patterns in Olmsted County may not be totally
generalizable to other settings due to a higher proportion of the working population being
employed in the health care industry and the correspondingly slightly higher education level.
Thus, we conclude from this population-based study that subjects with constipation are
greater utilizers of all types of medical services, and this is not explained by comorbid
conditions. Interventions to reduce the burden of constipation may be cost saving.
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Mean observed annual total costs for women with constipation versus controls according to
year.
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Mean observed annual outpatient costs of women with constipation versus controls
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Table 1
Medical index for disease (ICD-9 codes)
Disease ICD-9 codes
GI disease
 GERD or heartburn 530.1, 787.1
 Dyspepsia 536.8
 Abdominal pain 789.0
 Peptic ulcer disease 533. x
Non GI disease
 Headache, tension or migraine 784.0, 307.81, 346, 625.4, 784.0
 Thyroid disorder 245, 240.9, 244.2
 Diabetes mellitus 250.0
 Depression 296.2×, 296.89, 298.0, 300.4, 311
 Back pain 724.1, 724.2
 Limb pain 729.5, 729.4, 729.5
 Anxiety 300.00, 300.02, 300.09, 309.21
GERD=gastroesophageal reflux disease
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Table 2
A comparison of sociodemographic characteristics for subjects with constipation versus
controls
Cases N=168 Controls N=336 P-Value
Age of women in 1987, Mean (± SD) 33.2 (5.8) 33.2 (5.7) 0.9777
Follow-up years, Mean (± SD) 12.6 (2.5) 12.4 (2.6) 0.4079
Non legitimate birth (out of wedlock) 19 (11.3%) 34 (10.1%) 0.6813
Less than 18 at time of birth 6 (3.6%) 13 (3.9%) 0.8687
Maternal education level at child's birth < High School 15 (8.9%) 19 (5.7%) 0.1672
Prenatal visits, Mean (± SD) 11.4 (2.6) 11.1 (2.9) 0.2591
Proportion of cesarean delivery 14 (8.3%) 36 (10.7%) 0.3993
Complication of Delivery 64 (38.1%) 138 (41.1%) 0.5204
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Table 3
Proportion and Type of Co-morbid Medical Visits in Women with constipation or
controls between 1987-2002
Cases N=168 Controls N=336 P-value
# of non-users (1987-2002 Mayo) 4 (2.4%) 7 (2.1%) 0.8293
# of Patients with an Outpatient Visit(s) 129 (76.8%) 219 (65.2%) 0.0079
# of Patients with a Hospitalization(s) 126 (75.0%) 208 (61.9%) 0.0034
# of Patients with a ER Visit(s) 138 (82.1%) 233 (69.4%) 0.0021
Outpatient visits per patient per year, Mean (± SD) 0.17 (0.39) 0.12 (0.34) <0.0001
Inpatients stays per patient per year, Mean (± SD) 0.13 (0.33) 0.09 (0.28) <0.0001
ER Visits per patient per year, Mean (± SD) 0.24 (0.43) 0.15 (0.35) <0.0001
Comorbidities 142 (84.5%) 223 (66.4%) <0.0001
GI disease 79 (47.0%) 83 (24.7%) <0.0001
 GERD or heartburn 19 (11.3%) 23 (6.9%) 0.0874
 Dyspepsia 14 (8.3%) 20 (6.0%) 0.3151
 Abdominal pain 64 (38.1%) 65 (19.4%) <0.0001
 Peptic ulcer disease 4 (2.4%) 3 (0.9%) 0.2291
Non GI disease 136 (81.0%) 214 (63.7%) <0.0001
 Headache, tension or migraine 63 (37.5%) 81 (24.1%) 0.0017
 Thyroid disorder 19 (8.3%) 14 (5.7%) 0.2518
 Diabetes mellitus 5 (3.0%) 12 (3.6%) 0.7271
 Depression 71 (42.3%) 64 (19.1%) <0.0001
 Back pain 88 (52.4%) 105 (31.3%) <0.0001
 Limb pain 97 (57.7%) 116 (34.5%) <0.0001
 Anxiety 39 (23.2%) 37 (11.0%) 0.0003
GERD=Gastroesophageal reflux disease; ER=Emergency Room
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Table 4
Estimated Costs of women with constipation versus controls
Cases N=168 Controls N=336
Total Cost per Patient per Year1
 Mean $3,130.76 $1,858.34
 Q1-Q3 (1038.87, 3726.77) (490.83, 2186.12)
 Range (0, 44529.76) (0, 37879.79)
Outpatient Cost per Patient per Year1
 Mean $1,791.23 $963.90
 Q1-Q3 (788.94, 2254.25) (364.41, 1140.20)
 Range (0, 27916.58) (0, 12170.80)
Inpatient Cost per Patient per Year1
 Mean $1,294.08 $863.68
 Q1-Q3 (0, 1527.71) (0, 856.75)
 Range (0, 16369.97) (0, 36861.19)
Estimated Total Costs (All years)2 $63, 590.69 (49786.11, 81395.56) $24,529.25 (20666.73, 29260.46)
Estimated Outpatient Costs (All years)2 $38,897.27 (31380.72, 48253.02) $15,109.52 (12904.16, 17780.99)
Estimated total cost at 1990, Mean (95% CI) 3, 4 $2,162.88 (2094.59, 2239.16) $1,765.47 (1727.72, 1810.25)
Estimated total cost at 1995 3, 4 $3,545.55 (3295.75, 3821.43) $1,550.43 (1476.22, 1630.85)




Adjusted by Case vs. Control only.
3
Adjusting for case vs. control, abdominal pain, and back pain
4
CI calculating using bootstrap method
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Table 5
Multivariable predictors of costs for Cases
Predictor Outpatient Costs Total Costs
Predicted Change in Costs (%) P-Value Predicted Change in Costs (%) P -Value
Abdominal Pain 28.35 0.09 32.50 0.10
Heartburn/GERD 32.61 0.07 2.30 0.88
Dyspepsia -84.26 <0.0001 -76.79 0.0009
Depression 50.29 0.008 55.72 0.03
Anxiety -12.41 0.37 -24.02 0.18
Thyroid 4.02 0.89 -20.23 0.53
Headache -3.08 0.84 -24.68 0.17
Back Pain -4.58 0.82 1.34 0.96
Limb Pain 42.35 0.029 17.09 0.50
GERD=Gastroesophageal reflux disease
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